Maija Toropainen

2.0k citations
34 papers · 694 indexed · h-index 17

Maija Toropainen

34 papers receiving 669 citations

Peers

Maija Toropainen
Comparison fields: 5 of 68
  • Microbiology 386
  • Epidemiology 518
  • Clinical Biochemistry 35
  • Applied Microbiology and Biotechnology 10
  • Infectious Diseases 85
Replace Lucrecia Salazar with:
Lucrecia Salazar United States
Tuula Pelkonen Finland
Marjolein J. Lucas Netherlands
Masamitsu Kono Japan
Pier Giorgio Scotton Italy
Ana Cristina Paulo Portugal
Samileh Noorbakhsh Iran
Lykke Larsen Denmark
Helge Kjersem Denmark
Schaad Ub Switzerland
Maija Toropainen relative to Lucrecia Salazar United States Lucrecia Salazar's profile →
Citations per field
00.5×1.5×
Lucrecia Salazar · 1×
Citations per year

Countries citing papers authored by Maija Toropainen

Since Specialization
Citations

This map shows the geographic impact of Maija Toropainen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maija Toropainen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maija Toropainen more than expected).

Fields of papers citing papers by Maija Toropainen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maija Toropainen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maija Toropainen. The network helps show where Maija Toropainen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Maija Toropainen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Maija Toropainen Line = papers co-authored together Maija Toropainen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20245
3 20221
4 20217
5 20217
6 20205
7 201911
8 201848
9 201741
10 201719
11 201710
12 201521
13 201549
14 2015113
15 201427
16 20059
17 200521
18 200317
19 200119
20 199926

About Maija Toropainen

Maija Toropainen is a scholar working on Microbiology, Epidemiology and Biological Psychiatry, having authored 34 papers that have together received 694 indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (28 papers), Bacterial Infections and Vaccines (15 papers), Respiratory viral infections research (12 papers), Pneumocystis jirovecii pneumonia detection and treatment (10 papers), Streptococcal Infections and Treatments (5 papers), Neonatal and Maternal Infections (4 papers), Antimicrobial Resistance in Staphylococcus (4 papers) and Complement system in diseases (2 papers). The work is most often cited by research in Microbiology (386 citations), Epidemiology (518 citations) and Clinical Biochemistry (35 citations). Maija Toropainen has collaborated with scholars based in Finland, United States and Sweden. Frequent co-authors include J. Pekka Nuorti, Arto A. Palmu, Lotta Siira, Hanna Nohynek, Hanna Rinta‐Kokko, Jukka Jokinen, Helena Käyhty, Mikko Virtanen, Leena Saarinen and Anni Virolainen-Julkunen. Their work appears in journals such as PLoS ONE, PEDIATRICS and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026